Dose Ranging Study of ORKA-001 in Patients With Moderate-to-Severe Plaque Psoriasis

​ Conditions: Plaque Psoriasis

Interventions: Drug: ORKA-001; Other: Placebo

Sponsors: Oruka Therapeutics, Inc.

Recruiting Conditions: Plaque Psoriasis
Interventions: Drug: ORKA-001; Other: Placebo
Sponsors: Oruka Therapeutics, Inc.
Recruiting